Suppr超能文献

与前列腺癌相关的缺铁性贫血,并通过抗雄激素治疗得到改善。

Iron-Deficiency Anemia Associated With Prostate Cancer, and Ameliorated by Anti-androgen Therapy.

作者信息

Takenaka Tsuneo, Ozu Choichiro, Oshiba Yoko, Kawakami Yutaka, Okuda Makoto

机构信息

Nephrology, International University of Health and Welfare, Tokyo, JPN.

Urology, Sanno Hospital, Tokyo, JPN.

出版信息

Cureus. 2025 Jul 17;17(7):e88150. doi: 10.7759/cureus.88150. eCollection 2025 Jul.

Abstract

Hepcidin is synthesized in liver and is a master regulator of iron metabolism. Renal anemia was suspected in an 86-year-old man, who was referred to our department. Laboratory tests indicated iron-deficiency anemia (IDA), and ferrous sulphate was initiated. However, no bleeding sites were demonstrated and the response to iron supplementation was not satisfactory. MRI revealed a tumor in the prostate, and prostate biopsy showed poorly differentiated adenocarcinoma that was positive for hepcidin. Anti-androgen therapy ameliorated IDA. Potential roles of hepcidin from prostate cancer (PCa) in the pathogenesis of IDA are discussed in this article.

摘要

铁调素在肝脏中合成,是铁代谢的主要调节因子。一名86岁男性被转诊至我科,怀疑患有肾性贫血。实验室检查提示缺铁性贫血(IDA),遂开始使用硫酸亚铁治疗。然而,未发现出血部位,且补铁治疗效果不佳。磁共振成像(MRI)显示前列腺有肿瘤,前列腺活检显示为低分化腺癌,铁调素呈阳性。抗雄激素治疗改善了IDA。本文讨论了前列腺癌(PCa)来源的铁调素在IDA发病机制中的潜在作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验